Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus

L Watson1, K Tullus, S D Marks

  • 1Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Alder Hey Children's NHS Foundation Trust Hospital, Eaton Road, Liverpool, L12 2AP, UK. louise.watson@liverpool.ac.uk

Insights

Children with juvenile-onset systemic lupus erythematosus (JSLE) show higher serum concentrations of sphingosine-1-phosphate (S1P). This finding suggests S1P may play a role in JSLE

Area of Science:

  • Immunology
  • Rheumatology
  • Biochemistry

Background:

  • Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator implicated in inflammation and autoimmune diseases.
  • Elevated S1P levels are associated with various inflammatory conditions, but its role in pediatric autoimmune diseases remains under-explored.

Purpose of the Study:

  • To investigate serum and urinary concentrations of S1P in children diagnosed with juvenile-onset systemic lupus erythematosus (JSLE).
  • To compare S1P levels in JSLE patients with those in healthy controls and disease controls (Henoch Schonlein Purpura).

Main Methods:

  • A cross-sectional study involving JSLE patients from the UK JSLE Cohort Study.
  • Prospective collection of serum and urine samples, alongside clinical and demographic data.
  • Comparison of S1P levels against Henoch Schonlein Purpura (HSP) and healthy controls (HC).

Main Results:

  • Serum S1P concentrations were significantly elevated in JSLE patients compared to both HSP patients and healthy controls (p < 0.016 and p < 0.003, respectively).
  • A trend towards higher serum S1P was observed in JSLE patients with active lupus nephritis, though not statistically significant (p=0.355).
  • No significant difference in urine S1P concentrations was found between JSLE patients and healthy controls (p=0.889).

Conclusions:

  • This study provides the first evidence of increased serum S1P levels in a cohort of pediatric patients with JSLE.
  • The findings suggest a potential role for S1P in the underlying mechanisms of JSLE.
  • Further research is warranted to elucidate the specific contribution of S1P to JSLE pathophysiology.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...